Development of a New Live Attenuated Mumps Virus Vaccine in Human Deploid Cells

development of a new live attenuated mumps virus vaccine in human deploid cells

0

Development of a new live attenuated mumps virus vaccine in human diploid cells.

A new live attenuated mumps vaccine was developed in human diploid cells. The S-12 virus was isolated from a 10-year-old girl showing typical symptoms of mumps infection, the diagnosis was confirmed by a pediatrician. The virus was isolated in green monkey kidney cells, without passage in chick embryo cavity or chick embryo fibroblasts. Attenuation of the wild virus was performed by serial pass...

Development of an Attenuated Live Virus Vaccine against Sheep Pox

Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.

Mumps virus infection is a potentially serious viral infection of childhood and early adulthood. In China, live, attenuated S(79) mumps virus vaccine has been licensed for pediatric use since 1990. There has been no assessment of its efficacy. Thus, the objective of this study was to determine the effectiveness of live, attenuated S(79) mumps virus vaccine against clinical mumps. Cases were sel...

A review of prophylactic measure against brucellosis in human with a live attenuated vaccine

Isolation, Characterization and Standardization of New Infectious Bursal Disease Virus for Development of a Live Vaccine

Background and Aims: Infectious bursal disease (IBD) is an acute contagious viral disease of birds worldwide. The causative virus induces a persistent immune suppression following destroy B lymphocytes precursors in bursal lymphoid follicles. Vaccination is the main strategy for prevention of the disease in commercial poultry industry. Materials and Methods: To produce a live vaccine against th...